4.4 Article

Development of bone seeker radiopharmaceuticals by Scandium-47 and estimation of human absorbed dose

Journal

APPLIED RADIATION AND ISOTOPES
Volume 129, Issue -, Pages 108-116

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.apradiso.2017.07.062

Keywords

Radiophannaceuticals; Sc-47/46-HEDP; Sc-47/46-EDTMP; Biodistribution; Human dosimetry

Ask authors/readers for more resources

In this study labeling EDTMP (ethylenediamine tetra(methylene phosphonic acid)) and HEDP (Hydroxyethylidene-1, 1-Diphosphonic Acid) as the carrier ligands with Scandium-47 were investigated. The biokinetics of the bone seeking of labeled ligands with Scandium-47 were assessed by measuring the skeletal absorbed dose and then the mice data extrapolated to human absorbed dose and compared with the (186/188)Rhenium-HEDP, (153)Samarium-EDTMP dosimetry data estimated by other researchers. Because the availability of Sc-47 was limited we performed some preliminary studies using Sc-46.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available